AMBS FRIDAY GAZELLE PLAY Amarantus BioScience to Hold

New Post Public Reply Private Reply Replies (0) Message Board
Compensated Post
shakerzzz

AMBS >>FRIDAY GAZELLE PLAY

Amarantus BioScience to Hold Business Update Conference Call on April 16

2013-04-05 08:00 ET - News Release



SUNNYVALE, Calif. -- (Business Wire)

Amarantus BioScience, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases associated with neurodegeneration and apoptosis, today announced it will hold a conference call on Tuesday, April 16, 2013 at 4:30 p.m. Eastern (1:30 p.m. Pacific) to provide an update on its business and conduct a question and answer session with investors.

Individuals interested in listening to the conference call may do so by dialing 877-407-8033, or for international callers 201-689-8033. The call is also being webcast, and can be accessed from the Company’s Web site (www.amarantus.com) and at www.InvestorCalendar.com.

A telephone replay will be available through May 1, 2013 by dialing 877-660-6853, or for international callers 201-612-7415, and entering the Conference ID #: 411612. The webcast replay will be available for 90 days following the completion of the call.

During the call Amarantus Chief Executive Officer Gerald Commissiong will recap key accomplishments of 2012 and the first quarter of 2013, provide clarity on the Company’s recently updated business model and discuss business and product development initiatives planned for the remainder of 2013.

About Amarantus BioScience

Amarantus BioScience, Inc. is a development-stage biotechnology company founded in January 2008. The Company is focused on developing unique products and proprietary technologies for the potential treatment and/or diagnosis of Parkinson's disease, Traumatic Brain Injury, Ischemic Heart Disease and other human diseases. The Company owns the intellectual property rights to Mesencephalic-Astrocyte-derived Neurotrophic Factor ("MANF") and is developing MANF-based products as treatments for neurological disorders where there is a significant unmet medical need. The Company also is a Founding Member of the Coalition for Concussion Treatment (#C4CT), a movement initiated in collaboration with Brewer Sports International seeking to raise awareness of new treatments in development for concussions and related nervous-system disorders. For further information please visit www.Amarantus.com.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about the possible progress of the MANF technology in testing for Parkinson’s disease, as well as statements about expectations, plans and prospects of the development of Amarantus' diagnostic product candidates. These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including the risks associated with development of therapeutic drug candidates, as well as the risks, uncertainties and assumptions relating to the development of Amarantus' new product candidates, including those identified under "Risk Factors" in Amarantus' most recently filed Annual Report on Form 10-K and Quarterly Report on Form 10-Q and in other filings Amarantus periodically makes with the SEC. Actual results may differ materially from those contemplated by these forward-looking statements. Amarantus does not undertake to update any of these forward-looking statements to reflect a change in its views or events or circumstances that occur after the date of this presentation.




Contacts:

Investor/Media Contact
LHA
Don Markley, Senior Vice President
310-691-7100
dmarkley@lhai.com

Source: Amarantus BioScience, Inc.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 509

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 262

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 107

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 325

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 340

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 315

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 270

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 512

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 284

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 54

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading

Top 5 Most Recently Viewed Articles

Gran Tierra Energy's Strategic Vision for 2025 Growth

Updated Category News Views 271

Gran Tierra Energy's Ambitious Growth Forecast for 2025 Gran Tierra Energy Inc. (NYSE American: GTE) is setting the stage for a promising 2025 with its well-defined capital expenditure plans. As a significant player in the energy sector with operations in Colombia, Ecuador, and Canada, Gran Tierra targets a capital expenditure budget between $240 million and $280 million,...

Continue Reading
RHP Properties Commits $10,000 to Enhance Local Education

Updated Category News Views 160

RHP Properties Commits $10,000 to Enhance Local Education RHP Properties, a leader in managing manufactured home communities for over three decades, has taken a notable step in supporting local education by donating $10,000 to Sunnyside High School through AdoptAClassroom.org. This nonprofit organization is dedicated to providing essential funding for classrooms from PreK...

Continue Reading
Qetaifan Projects Unveils Record-Setting Waterslide Attraction

Updated Category News Views 210

Qetaifan Projects Celebrates World Record Milestones Qetaifan Projects, part of Katara Hospitality, has made incredible strides in the world of amusement and water parks with its flagship attraction, 'The RIG 1938'. This remarkable ridescape has recently achieved recognition from Guinness World Records™ for two impressive feats: it holds the title for the tallest...

Continue Reading
Exploring Innovative Dogecoin Cloud Mining with VNBTC

Updated Category News Views 94

Revolutionizing Dogecoin Cloud Mining with VNBTC In 2025, Dogecoin cloud mining made a remarkable transition from a niche hobby to a mainstream avenue for enthusiasts and investors alike. VNBTC cloud mining has emerged as a key player in this exciting landscape by offering an array of flexible cloud mining contracts that cater to users of all experience levels. Their...

Continue Reading
GigaCloud Technology Welcomes Kerry Lebensburger to Board

Updated Category News Views 139

GigaCloud Technology's New Board Addition GigaCloud Technology Inc (NASDAQ: GCT), known for pioneering global B2B technology solutions for large parcel merchandise, has recently welcomed Kerry Lebensburger to its Board of Directors. This appointment comes as the company continues its impressive journey in the industry, aligning with a potent era of innovation and...

Continue Reading